Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GGHCX vs LYFIX overlap: 17% of top holdings shared

Bottom line

How much do GGHCX and LYFIX overlap?

17% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 14.5% of GGHCX's assets and 19.8% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

GGHCXLYFIX
Weight overlap (top 25)17%
Shared holdings5
Weight in shared holdings14.5%19.8%
Total positions8262
Expense ratio1.07%1.41%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings GGHCX and LYFIX have in common

Holding% of GGHCX% of LYFIXOverlap
AbbVie Inc.4.03%1.95%1.95%
Gilead Sciences, Inc.3.63%5.53%3.63%
argenx SE3.24%3.59%3.24%
Vertex Pharmaceuticals Inc.2.01%5.33%2.01%
Axsome Therapeutics, Inc.1.58%3.43%1.58%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GGHCX

  1. Eli Lilly and Co. — 10.59%
  2. Johnson & Johnson — 6.76%
  3. UnitedHealth Group Inc. — 6.17%
  4. Invesco Private Prime Fund — 4.67%
  5. Merck & Co., Inc. — 4.59%
  6. CVS Health Corp. — 2.52%
  7. Welltower Inc. — 2.34%
  8. BrightSpring Health Services, Inc. — 2.20%
  9. Royalty Pharma PLC — 2.13%
  10. Cardinal Health, Inc. — 2.10%
  11. Guardant Health, Inc. — 2.04%
  12. Invesco Private Government Fund — 1.80%
  13. Edwards Lifesciences Corp. — 1.56%
  14. Invesco Treasury Portfolio — 1.56%
  15. Thermo Fisher Scientific Inc. — 1.55%

Only in LYFIX

  1. Astrazeneca Plc — 4.63%
  2. First American Funds Inc — 4.26%
  3. Roivant Sciences Ltd — 3.67%
  4. Neurocrine Biosciences Inc — 3.51%
  5. Incyte Corp — 3.51%
  6. Apogee Therapeutics Inc — 3.28%
  7. Ionis Pharmaceuticals Inc — 2.62%
  8. Ascendis Pharma A/s — 2.62%
  9. Insmed Inc — 2.60%
  10. Protagonist Therapeutics Inc — 2.41%
  11. Personalis Inc — 2.27%
  12. Rhythm Pharmaceuticals Inc — 2.25%
  13. Jazz Pharmaceuticals Plc — 1.87%
  14. Amgen Inc — 1.83%
  15. Biogen Inc — 1.80%

Asset mix

Asset typeGGHCXLYFIX
Stocks97.5%95.8%
Cash & short-term funds8.8%4.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryGGHCXLYFIX
US93.5%76.0%
NL3.4%4.7%
GB3.1%4.6%
BM—3.7%
FR—2.8%
CH2.7%—
DK1.1%2.6%
IE0.6%2.4%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do GGHCX and LYFIX overlap?
About 17% by weight. 5 securities appear in both funds' top 25 holdings; they make up 14.5% of GGHCX's assets and 19.8% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do GGHCX and LYFIX have in common?
The largest shared holdings are Gilead Sciences, Inc., argenx SE, Vertex Pharmaceuticals Inc., AbbVie Inc., Axsome Therapeutics, Inc..
Should I own both GGHCX and LYFIX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, GGHCX or LYFIX?
GGHCX is broader, with 82 positions versus 62 for LYFIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.